Skip to content
MCT LOGO
MCT CRO

  • HOME
  • ABOUT US
    • Who We Are
    • Mission & Value
    • Management
    • Quality
    • Geographical Coverage
  • CRO SERVICES
    • Site Selection & Feasibility
    • Regulatory Submissions
    • Monitoring
    • Project Management
    • Data Management & Stat
    • Medical Writing
    • Pharmacovigilance
    • Training & Quality Assurance
    • Staff Outsourcing
  • REGIONAL REACH
    • Middle East
    • North Africa
    • Sub-Saharan Africa
    • Pakistan
  • EXPERIENCES
    • By Phase
    • By Indication
    • References
  • CLINICAL RESEARCH IN MEA and Pakistan
    • Why going to MENA and Pakistan
    • Regulatory & Useful Links
  • CAREER
    • Job Descriptions
    • Open Positions
  • NEWS
    • Newsletter
  • CONTACT
    • Becoming an Investigator
    • MCT in China
    • For any question, please contact BD@mct-cro.com
Search
MCT LOGO
MCT CRO

  • HOME
  • ABOUT US
    • Who We Are
    • Mission & Value
    • Management
    • Quality
    • Geographical Coverage
  • CRO SERVICES
    • Site Selection & Feasibility
    • Regulatory Submissions
    • Monitoring
    • Project Management
    • Data Management & Stat
    • Medical Writing
    • Pharmacovigilance
    • Training & Quality Assurance
    • Staff Outsourcing
  • REGIONAL REACH
    • Middle East
    • North Africa
    • Sub-Saharan Africa
    • Pakistan
  • EXPERIENCES
    • By Phase
    • By Indication
    • References
  • CLINICAL RESEARCH IN MEA and Pakistan
    • Why going to MENA and Pakistan
    • Regulatory & Useful Links
  • CAREER
    • Job Descriptions
    • Open Positions
  • NEWS
    • Newsletter
  • CONTACT
    • Becoming an Investigator
    • MCT in China
    • For any question, please contact BD@mct-cro.com

MCT Insights – Perspectives on issues that are reshaping Clinical Research in Middle East and Africa : Sickle Cell Disease in West Africa

/ News / March 5, 2019

20190305 MCT Insights_Sickle cell disease West Africa

Post navigation
← Previous Post
Next Post →

Related Posts

MCT’s collaboration with Onxeo on HCC Phase III study in Middle East

News / March 26, 2015

Onxeo has engaged MCT (Regional CRO specialized on Middle East and Africa) to expand “Relieve” phase III HCC study in 3 Middle East countries (Lebanon,…

Job opportunities: Experienced CRAs in Jordan, Egypt and Tunisia

News / October 9, 2013

MCT is looking for Senior Clinical Research Associates (SCRA) for our operations in Jordan, Egypt and Tunisia. Minimum of 2 years experience in R&D studies…

MCT LOGO
FacebookTwitterLinkedin

Copyright © 2025 MCT CRO | All Rights Reserved